No abstract available
MeSH terms
-
Angioplasty, Balloon, Coronary* / adverse effects
-
Angioplasty, Balloon, Coronary* / mortality
-
Anticoagulants / administration & dosage*
-
Anticoagulants / adverse effects
-
Enoxaparin / administration & dosage*
-
Enoxaparin / adverse effects
-
Fibrinolytic Agents / administration & dosage*
-
Fibrinolytic Agents / adverse effects
-
Hemorrhage / etiology
-
Hemorrhage / mortality
-
Heparin / administration & dosage*
-
Heparin / adverse effects
-
Humans
-
Injections, Intravenous
-
Myocardial Infarction / etiology
-
Myocardial Infarction / mortality
-
Patient Selection
-
Platelet Aggregation Inhibitors / therapeutic use
-
Practice Guidelines as Topic
-
Risk Assessment
-
Risk Factors
-
Time Factors
-
Treatment Outcome
Substances
-
Anticoagulants
-
Enoxaparin
-
Fibrinolytic Agents
-
Platelet Aggregation Inhibitors
-
Heparin